Prediction of potential active ingredients and mechanism of Forsythia suspense leaf green tea extract in treating COPD mice based on UPLC ‐ MS and network pharmacology
Journal of the Science of Food and Agriculture · 2025
DOI: 10.1002/jsfa.14264 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Science of Food and Agriculture, 2025. Verfasst von Xuli Zuo und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China. Hauptthemen laut MEDLINE: Plant Extracts, Forsythia, Pulmonary Disease, Chronic Obstructive. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Shanxi Jin 'an Pharmaceutical Ecological Technology Co., Ltd.
Themen: COPD
Abstract (Originalsprache)
BACKGROUND Chronic obstructive pulmonary disease (COPD) is a common chronic respiratory disease and the third leading cause of death worldwide, with chronic inflammation as its primary pathogenesis. The dried leaves of Forsythia suspensa (Thunb.) have anti‐inflammatory pharmacological activity and potential clinical promise for the treatment of COPD; however, its pharmacodynamic activity and mechanism of action remain to be clarified. RESULTS In total, 82 compounds were identified from F . suspense leaf green tea extract (STW), mainly lignans, flavonoids, phenolic acids and phenylethanol glycosides, were identified in STW. STW alleviates enlargement of the alveolar sac and cavity, thickening of the alveolar wall and infiltration of inflammatory cells in COPD mice. In the model group, the contents of interleukin (IL)‐6, tumor necrosis factor (TNF)‐α, IL‐8, IL‐1β and malondialdehyde were decreased, and the levels of superoxide dismutase and catalase were increased in a dose‐dependent manner ( P < 0.05). Network pharmacological analysis identified 19 active STW components and 81 potential targets for the treatment of COPD. The key components include quercetin, ferulic acid, phillygenin, rutin and phillyri, whereas the core targets included TNF, protein kinase B alpha, epidermal growth factor receptor and metalloproteinase‐9. Mainly through phosphatidylinositol 3‐kinase/protein kinase B, calcium ions, nuclear factor‐kappa B and other signaling pathways. CONCLUSION STW affects multiple pathways and targets in the treatment of COPD, and mainly plays a role in alleviating pulmonary inflammation. © 2025 Society of Chemical Industry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
- Xi'an Mental Health Center, Xi'an, China.
- Shanxi Jin'an Pharmaceutical Ecological Technology Co., Ltd, Linfen, China.
ORCID-Profile: Xuli Zuo, Yu Wang, Weidong Li
Förderung
- Shanxi Jin 'an Pharmaceutical Ecological Technology Co., Ltd
Zitieren
APA
Zuo, X., Pan, X., Wang, Y., Li, Z., & Li, W. (2025). Prediction of potential active ingredients and mechanism of Forsythia suspense leaf green tea extract in treating COPD mice based on UPLC ‐ MS and network pharmacology. Journal of the Science of Food and Agriculture. https://doi.org/10.1002/jsfa.14264
Vancouver
Zuo X, Pan X, Wang Y, Li Z, Li W. Prediction of potential active ingredients and mechanism of Forsythia suspense leaf green tea extract in treating COPD mice based on UPLC ‐ MS and network pharmacology. Journal of the Science of Food and Agriculture. 2025. doi:10.1002/jsfa.14264
BibTeX
@article{Zuo2025,
author = {Zuo, Xuli and Pan, Xiuzhen and Wang, Yu and Li, Zhenghao and Li, Weidong},
title = {Prediction of potential active ingredients and mechanism of Forsythia suspense leaf green tea extract in treating COPD mice based on UPLC ‐ MS and network pharmacology},
journal = {Journal of the Science of Food and Agriculture},
year = {2025},
doi = {10.1002/jsfa.14264}
}
EUVIMED